MedAdvisor Limited (ASX:MDR)
Australia
· Delayed Price · Currency is AUD 0.0960
0.00 (0.00%)
Apr 23, 2025, 3:03 PM AEST
MedAdvisor Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 103.66 | 122.11 | 97.96 | 67.75 | 38.77 | 9.6 | Upgrade
|
| Revenue | 103.66 | 122.11 | 97.96 | 67.75 | 38.77 | 9.6 | Upgrade
|
| Revenue Growth (YoY) | -5.27% | 24.64% | 44.59% | 74.74% | 303.77% | 16.51% | Upgrade
|
| Cost of Revenue | 83.42 | 94.19 | 81.18 | 71.15 | 46.43 | 11.99 | Upgrade
|
| Gross Profit | 20.24 | 27.92 | 16.78 | -3.4 | -7.66 | -2.39 | Upgrade
|
| Selling, General & Admin | 13.22 | 14.97 | 13.24 | 2.66 | 2.53 | 5.88 | Upgrade
|
| Other Operating Expenses | 5.62 | 5.96 | 5.22 | 5.24 | 4.93 | 0.99 | Upgrade
|
| Operating Expenses | 22.61 | 25.13 | 23.81 | 12.79 | 10.67 | 7.39 | Upgrade
|
| Operating Income | -2.37 | 2.79 | -7.03 | -16.19 | -18.33 | -9.77 | Upgrade
|
| Interest Expense | -2.18 | -1.93 | -2.13 | -1.54 | -0.41 | -0.09 | Upgrade
|
| Interest & Investment Income | 0.17 | 0.16 | 0.05 | 0 | 0.04 | 0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 1.47 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -4.37 | 1.02 | -9.11 | -17.73 | -17.23 | -9.78 | Upgrade
|
| Merger & Restructuring Charges | -0.09 | -0.09 | -1.4 | - | - | - | Upgrade
|
| Pretax Income | -4.47 | 0.92 | -10.52 | -17.73 | -17.23 | -9.78 | Upgrade
|
| Income Tax Expense | 0.21 | 0.13 | 0.79 | -0.24 | -2.86 | - | Upgrade
|
| Earnings From Continuing Operations | -4.68 | 0.79 | -11.31 | -17.49 | -14.37 | -9.78 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0.14 | 0.42 | 0.19 | Upgrade
|
| Net Income | -4.68 | 0.79 | -11.31 | -17.35 | -13.95 | -9.58 | Upgrade
|
| Net Income to Common | -4.68 | 0.79 | -11.31 | -17.35 | -13.95 | -9.58 | Upgrade
|
| Shares Outstanding (Basic) | 551 | 548 | 545 | 378 | 317 | 232 | Upgrade
|
| Shares Outstanding (Diluted) | 551 | 597 | 545 | 378 | 317 | 232 | Upgrade
|
| Shares Change (YoY) | -1.88% | 9.57% | 44.12% | 19.47% | 36.47% | 21.09% | Upgrade
|
| EPS (Basic) | -0.01 | 0.00 | -0.02 | -0.05 | -0.04 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | 0.00 | -0.02 | -0.05 | -0.04 | -0.04 | Upgrade
|
| Free Cash Flow | -12.12 | 5.12 | -1.63 | -0.55 | -12.94 | -8.78 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | 0.01 | -0.00 | -0.00 | -0.04 | -0.04 | Upgrade
|
| Gross Margin | 19.53% | 22.86% | 17.13% | -5.01% | -19.75% | -24.86% | Upgrade
|
| Operating Margin | -2.29% | 2.28% | -7.18% | -23.89% | -47.27% | -101.78% | Upgrade
|
| Profit Margin | -4.51% | 0.65% | -11.54% | -25.60% | -35.98% | -99.82% | Upgrade
|
| Free Cash Flow Margin | -11.70% | 4.20% | -1.67% | -0.81% | -33.36% | -91.45% | Upgrade
|
| EBITDA | -2.39 | 4.18 | -4.78 | -14.36 | -17.18 | -9.65 | Upgrade
|
| EBITDA Margin | -2.31% | 3.42% | -4.87% | -21.20% | -44.31% | -100.47% | Upgrade
|
| D&A For EBITDA | -0.02 | 1.39 | 2.26 | 1.83 | 1.15 | 0.13 | Upgrade
|
| EBIT | -2.37 | 2.79 | -7.03 | -16.19 | -18.33 | -9.77 | Upgrade
|
| EBIT Margin | -2.29% | 2.28% | -7.18% | -23.89% | -47.27% | -101.78% | Upgrade
|
| Effective Tax Rate | - | 14.23% | - | - | - | - | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.